 |
| | Business Summary: BioLargo, Inc. engages in licensing its BioLargo technology. | | | Address
2603 Main St Ste 1155
Irvine
, CA 92614
Phone: 949-235-8062
Website: http://www.biolargo.com
| | Auditor |
|---|
Jeffrey S. Gilbert
Los Angeles | | Transfer Agent |
|---|
American Stock Transfer & Trust Co.
| Employees: 3
ShareHolders: 429 | Founded: 1989
Domicile: Delaware | | | |
| | BioLargo, Inc. engages in licensing its BioLargo technology. Its BioLargo technology consists of intellectual property, including two patents relating to a process whereby disinfecting chemistry is incorporated into absorbent products, such as bed pads, blood pads, diapers, surgical drapes, transportation packages for protective liners, wound dressings, bandages, as well as liquids, powders, washes, sprays, tablets, or other delivery methods. The company is based in Irvine, California. | | History: INCORPORATED in Delaware Sept. 19, 1991 as Repossession Auction, Inc.; and on Sept. 30, 1991, merged predecessor, a Florida corporation of the same name organized Dec. 11, 1989. Name changed to Latin American Casinos, Inc. June 16, 1994; to NuWay Energy, Inc. Aug. 13, 2001; to NuWay Medical Inc. Oct. 30, 2002; and to BioLargo, Inc. Mar. 16, 2007.
October 1, 2002, sold the oil and gas operations of NuWay Resources Ltd. to Summit Oil and Gas, Inc. for $100,000 less all outstanding liabilities of NuWay Resources. As the offsetting liabilities exceeded the purchase price, the company received no funds.
October 1, 2002, sold the stock of its wholly owned casino rental subsidiaries (Latin American Casinos del Peru S.A. and Latin American Casinos of Colombia, LTDA) to Casino Venture Partners, a Nevada partnership for $300,000 less all outstanding liabilities of the two subsidiaries. As the offsetting liabilities exceeded the purchase price, the company received no funds.
April 30, 2007, completed the acquisition of the BioLargo technology from IOWC Technologies, Inc. for 22,139,012 Common shares. | | | | Subsidiaries: |
|---|
BioLargo Life Technologies, Inc.
| | | | Backlog |
|---|
| Year | Currency | Amount |
|---|
| 2006 | US Dollars | 0(thousand) |
| | 2005 | US Dollars | 0(thousand) |
| | | | Capital Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2008 | 29 |
| | | | | | Research and Development Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2008 | 114 |
| | | | | | | |
|
Management
|
|---|
| Officers | Position |
|---|
| Dennis P. Calvert | Chairman, President, Chief Executive Officer & Investor Relations Contact | | Charles K. Dargan, II | Chief Financial Officer & Chief Accounting Officer | | Joseph L. Provenzano | Secretary & Chief Operating Officer | | Kenneth Reavy Code | Chief Technology Officer |
| | Directors |
|---|
| Dennis P. Calvert | | Kenneth Reavy Code | | Gary A. Cox | | Dennis E. Marshall | | Joseph L. Provenzano | | | |
| | | | Capitalization as of 06/30/2008: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Preferred $0.00067 par | 50,000,000 | None | | Common $0.00067 par | 200,000,000 | 40,592,247 |
| | | | LONG TERM DEBT: $426,037. | | | | Common $0.00067 par | | | |
Stockholders:
03/31/2008,
429.
| | PRINCIPAL STOCKHOLDERS: March 31, 2008, Kenneth R. Code owned or controlled 56.2% of the Common, and Dennis Calvert 11.9%. | | | |
Transfer Agent: American Stock Transfer & Trust Co.
Brooklyn
, NY | | | | OTC Bulletin Board( Primary): BLGO | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2008 | 2.0000 | 0.3000 | | Over The Counter | 2007 | 1.0100 | 0.0100 | | Over The Counter | 2006 | 0.0400 | 0.0100 | | Over The Counter | 2005 | 0.0400 | 0.0010 | | Over The Counter | 2004 | 0.0600 | 0.0007 | | Over The Counter | 2003 | 0.3500 | 0.0300 | | NASDAQ Small Cap | 2002 | 2.1500 | 0.0700 | | NASDAQ | 2001 | 4.2500 | 1.6700 | | NASDAQ | 2000 | 2.5000 | 1.0310 | | NASDAQ | 1999 | 1.8750 | 0.8750 |
|
| | | | RECENT DIVIDENDS: Common $0.00067 par: No cash.
Common reverse split 1-for-25, Mar. 21, 2007. | | | | | |
| | Annual Report |
|---|
| | | Income Statement | |
| 2008 | 2007 |
|---|
| REVENUES |
|
| | Revenues | - | 80,000 | | Total Revenues | - | 80,000 | | EXPENSES |
|
| | Selling, General and Administrative | (4,829,061) | (2,994,516) | | Research and Development | (113,748) | (131,349) | | Amortization | (1,109,940) | (738,136) | | Interest Expense | (1,149,986) | (1,564,312) | | Other Income | 59,985 | 88,923 | | Earnings before Taxes | (7,142,750) | (5,259,390) | | TAXES AND OTHER EXPENSES |
|
| | Net Income (Loss) | (7,142,750) | (5,259,390) | | SUPPLEMENTARY INFO |
|
| | Operating Income (Loss) | (6,052,749.00) | (3,864,001.00) | | Basic Eps-continuing Operations | (0.17) | (0.18) |
| | | | Balance Sheet | |
| 2008 | 2007 |
|---|
| CURRENT ASSETS |
|
| | Cash and Cash Equivalents | 90,384 | 457,809 | | Prepaid Expenses | 4,586 | 4,584 | | Total Current Assets | 94,970 | 462,393 | | NON CURRENT ASSETS |
|
| | Equipment (Net) | 25,954 | - | | Licensing Rights, Net | 9,633,052 | 10,655,164 | | Assigned Agreements, Net | 255,285 | 340,377 | | Total Assets | 10,009,261 | 11,457,934 | | CURRENT LIABILITIES |
|
| | Accounts Payable and Accrued Expenses | 993,431 | 781,221 | | Accrued Option Compensation Expense | 657,801 | 635,845 | | Notes Payable | - | 22,076 | | Convertible Notes Payable, Current Portion | 431,262 | 556,788 | | Total Current Liabilities | 2,082,494 | 1,995,930 | | NON CURRENT LIABILITIES |
|
| | Convertible Notes Payable, Net of Current Portion | 572,675 | 426,037 | | SHAREHOLDERS' EQUITY |
|
| | Common Stock-par Value | 28,319 | 26,779 | | Additional Paid in Capital | 49,481,804 | 44,022,472 | | Accumulated Deficit | (42,156,032) | (35,013,284) | | Total Shareholders Equity | 7,384,894 | 9,035,967 | | Total Liabilities & Shareholders Equity | 10,009,261 | 11,457,934 |
| | | |
| | Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2007 |
1 | Nil | | 2007 |
2 | Nil | | 2007 |
3 | Nil | | 2007 |
4 | 70,000 | | 2007 |
Full Year
| 80,000 | | 2006 |
1 | Nil | | 2006 |
2 | Nil | | 2006 |
3 | Nil | | 2006 |
Full Year
| Nil | | 2005 |
1 | Nil | | 2005 |
2 | Nil | | 2005 |
3 | Nil | | 2005 |
Full Year
| Nil | | 2004 |
1 | Nil | | 2004 |
2 | Nil | | 2004 |
3 | Nil | | 2004 |
Full Year
| Nil |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2009 |
1 | (1,710,000) | | 2008 |
2 | (1,660,000) | | 2008 |
3 | (1,550,000) | | 2008 |
4 | (1,520,000) | | 2008 |
Full Year
| (7,140,000) | | 2007 |
1 | (1,590,000) | | 2007 |
2 | (700,000) | | 2007 |
3 | (480,000) | | 2007 |
Full Year
| (5,260,000) | | 2006 |
1 | (440,000) | | 2006 |
2 | (10,000) | | 2006 |
3 | (650,000) | | 2006 |
Full Year
| (1,520,000) | | 2005 |
1 | (240,000) | | 2005 |
2 | (230,000) | | 2005 |
3 | (420,000) | | 2005 |
Full Year
| (1,187,300) | | 2004 |
1 | (470,000) | | 2004 |
2 | (330,000) | | 2004 |
3 | (170,000) | | 2004 |
Full Year
| (1,218,000) |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2009 |
1 | (.04) | | 2008 |
1 | (.06) | | 2008 |
2 | (.04) | | 2008 |
3 | (.04) | | 2008 |
4 | (.04) | | 2008 |
Full Year
| (.17) | | 2007 |
1 | (.37) | | 2007 |
2 | (.02) | | 2007 |
3 | (.01) | | 2007 |
4 | (.03) | | 2007 |
Full Year
| (.18) | | 2006 |
1 | (.25) | | 2006 |
2 | (.25) | | 2006 |
3 | (.25) | | 2006 |
4 | (.11) | | 2006 |
Full Year
| (.48) | | 2005 |
1 | (.25) | | 2005 |
2 | (.25) | | 2005 |
3 | (.25) | | 2005 |
Full Year
| (.50) | | 2004 |
1 | (.25) | | 2004 |
2 | (.25) | | 2004 |
3 | (.25) | | 2004 |
Full Year
| (.75) |
| | | |
| |
|
